BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27267876)

  • 1. Addressing antimicrobial resistance in China: policy implementation in a complex context.
    Wang L; Zhang X; Liang X; Bloom G
    Global Health; 2016 Jun; 12(1):30. PubMed ID: 27267876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of a ban on outpatient intravenous antibiotic therapy among the secondary and tertiary hospitals in China.
    Wang X; Wu D; Xuan Z; Wang W; Zhou X
    BMC Public Health; 2020 Nov; 20(1):1794. PubMed ID: 33239002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inequality and antibiotic resistance: A contractualist perspective.
    Millar M
    Bioethics; 2019 Sep; 33(7):749-755. PubMed ID: 31423607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Situational analysis of antibiotic use and resistance in Ghana: policy and regulation.
    Yevutsey SK; Buabeng KO; Aikins M; Anto BP; Biritwum RB; Frimodt-Møller N; Gyansa-Lutterodt M
    BMC Public Health; 2017 Nov; 17(1):896. PubMed ID: 29169340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs.
    O'Connor S; Rifkin D; Yang YH; Wang JF; Levine OS; Dowell SF
    Pediatr Infect Dis J; 2001 Jul; 20(7):679-84. PubMed ID: 11465840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding how to improve physicians' paradigms for prescribing antibiotics by using a conceptual design framework: a qualitative study.
    Zhu E; Fors U; Smedberg Å
    BMC Health Serv Res; 2018 Nov; 18(1):860. PubMed ID: 30428866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial resistance to antibiotics: access, excess, and awareness in Bangladesh.
    Islam MM
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):973-981. PubMed ID: 33353447
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventions to improve antibiotic prescribing practices for hospital inpatients.
    Davey P; Brown E; Charani E; Fenelon L; Gould IM; Holmes A; Ramsay CR; Wiffen PJ; Wilcox M
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003543. PubMed ID: 23633313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing antibiotic prescribing in Australian general practice: time for a national strategy.
    Del Mar CB; Scott AM; Glasziou PP; Hoffmann T; van Driel ML; Beller E; Phillips SM; Dartnell J
    Med J Aust; 2017 Nov; 207(9):401-406. PubMed ID: 29092694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the veterinary antibiotics supply chain to address antimicrobial resistance in Lao PDR: Roles and interactions of involved stakeholders.
    Poupaud M; Putthana V; Patriarchi A; Caro D; Agunos A; Tansakul N; Goutard FL
    Acta Trop; 2021 Aug; 220():105943. PubMed ID: 33965370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tackling anti-microbial resistance: ethical framework for rational antibiotic use.
    Littmann J; Rid A; Buyx A
    Eur J Public Health; 2018 Apr; 28(2):359-363. PubMed ID: 29036540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citizens' juries: the public verdict on antibiotic resistance.
    Burki T
    Lancet Respir Med; 2016 Oct; 4(10):779. PubMed ID: 27567071
    [No Abstract]   [Full Text] [Related]  

  • 13. How effective and cost-effective are behaviour change interventions in improving the prescription and use of antibiotics in low-income and middle-income countries? A protocol for a systematic review.
    Batura N; Cuevas C; Khan M; Wiseman V
    BMJ Open; 2018 May; 8(5):e021517. PubMed ID: 29764887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of Primary Care Physician System on Healthcare Utilization and Antibiotic Prescription: Difference-in-Differences and Causal Mediation Analyses.
    Okubo Y; Michihata N; Uda K; Kinoshita N; Horikoshi Y; Miyairi I
    Pediatr Infect Dis J; 2020 Oct; 39(10):937-942. PubMed ID: 32502123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Thern J; Kern WV
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(7):511-4. PubMed ID: 26593766
    [No Abstract]   [Full Text] [Related]  

  • 16. More action, less resistance: report of the 2014 summit of the Global Respiratory Infection Partnership.
    Altiner A; Bell J; Duerden M; Essack S; Kozlov R; Noonan L; Oxford J; Pignatari AC; Sessa A; van der Velden A
    Int J Pharm Pract; 2015 Oct; 23(5):370-7. PubMed ID: 25711969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance and policy in Belgium.
    Goossens H
    Verh K Acad Geneeskd Belg; 2000; 62(5):439-69. PubMed ID: 11144690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an antimicrobial stewardship programme on antibiotic usage and resistance in a tertiary hospital in China.
    Zhang ZG; Chen F; Ou Y
    J Clin Pharm Ther; 2017 Oct; 42(5):579-584. PubMed ID: 28485087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program.
    Chen M; Wang L; Chen W; Zhang L; Jiang H; Mao W
    Pharmacoeconomics; 2014 Mar; 32(3):245-55. PubMed ID: 23813440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence of antibiotic resistance: myths and facts in clinical practice.
    Hamilton-Miller JM
    Intensive Care Med; 1990; 16 Suppl 3():S206-11. PubMed ID: 2289992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.